Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Ophthalmology|April 5, 2019
Ipsilateral metastatic choroidal melanoma responds to systemic immunotherapyMoanes Morkos, Puneet Jain, Anna C Pavlick, et al.
European Journal of Ophthalmology|March 30, 2011
Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanomaHadas Newman, Paul T Finger, Kimberly J Chin, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Frontline Therapy for BRAF-Mutated Metastatic Melanoma: How Do You Choose, and Is There One Correct Answer?Anna C Pavlick, Leslie Fecher, Paolo A Ascierto, et al.
Future Oncology (London, England)|October 21, 2020
First-line immunotherapy versus targeted therapy in patients with BRAF-mutant advanced melanoma: a real-world analysisAnna C Pavlick, Ruizhi Zhao, Cho-Han Lee, et al.
Facial Plastic Surgery : FPS|May 16, 2020
Current Research in Melanoma and Aggressive Nonmelanoma Skin CancerReason Wilken, Maressa Criscito, Anna C Pavlick, et al.
American Journal of Ophthalmology|July 5, 2005
Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanomaMadhavi Kurli, Shantan Reddy, Lawrence B Tena, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 29, 2016
Metastatic Cutaneous Squamous Cell Carcinoma: The Importance of T2 Stratification and Hematologic Malignancy in PrognosticationMary L Stevenson, Randie Kim, Shane A Meehan, et al.
Oncology|September 7, 2020
Management of Melanoma during Pregnancy: A Case Series of 11 Women Treated at NYU Langone HealthAmelia E Sawyers, Anna C Pavlick, Jeffrey S Weber, et al.
Melanoma Research|June 9, 2022
Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanomaJeffrey S Weber, Benjamin A Levinson, Andressa S Laino, et al.
Investigational New Drugs|July 3, 2010
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancerMargarette Bryan, E Dianne Pulte, Kathleen C Toomey, et al.
Pageof 11